文献速递白血病

不同骨髓部位对T细胞急性淋巴细胞白血病休眠与化疗耐药的不同印记

Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia.
PubMed 文献 · Blood Adv · 2017-09-08

研究利用体内动物模型观察不同骨髓部位对T细胞急性淋巴细胞白血病(T-ALL)增殖的影响。小鼠及人T-ALL在尾椎骨髓中较胸椎骨髓生长缓慢,从尾椎骨髓回收的T-ALL呈休眠表型、短期体外生长缺陷、体内增殖延迟,且对细胞周期相关药物(长春新碱、阿糖胞苷)固有耐药更高。

要点

  • 尾椎骨髓来源的T-ALL较胸椎骨髓生长缓慢,呈休眠表型
  • 尾椎来源T-ALL短期体外生长缺陷、体内增殖延迟
  • 尾椎来源T-ALL对长春新碱和阿糖胞苷固有耐药更高

核心结论

  • 骨髓部位差异性地调控T-ALL增殖,并赋予白血病细胞静息状态和对细胞周期依赖性化疗反应降低等特定特征。

研究设计与样本

  • 采用体内动物模型研究不同骨髓部位对T-ALL增殖的调控作用。

主要发现

  • 小鼠及人T-ALL在尾椎骨髓中较胸椎骨髓生长缓慢,从尾椎骨髓回收的T-ALL细胞表面标志物表达降低、代谢下降、细胞周期进展减慢,呈休眠表型。
  • 尾椎来源T-ALL短期体外生长缺陷、体内增殖延迟,这些特征为非细胞自主性,因尾椎与胸椎来源T-ALL基因组异常相同,且功能差异在体内及长时间体外培养中消失。
  • 尾椎来源T-ALL对细胞周期相关药物(长春新碱硫酸盐和阿糖胞苷)固有耐药更高;从性腺脂肪组织或与脂肪细胞共培养回收的T-ALL与尾椎来源T-ALL在代谢、细胞周期、表型或化疗耐药特征上相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

T-cell acute lymphoblastic leukemia (T-ALL) expands in various bone marrow (BM) sites of the body. We investigated whether different BM sites could differently modulate T-ALL propagation using in vivo animal models. We observed that mouse and human T-ALL develop slowly in the BM of tail vertebrae compared with the BM from thorax vertebrae. T-ALL recovered from tail BM displays lower cell-surface marker expression and decreased metabolism and cell-cycle progression, demonstrating a dormancy phenotype. Functionally, tail-derived T-ALL exhibit a deficient short-term ex vivo growth and a delayed in vivo propagation. These features are noncell-autonomous because T-ALL from tail and thorax shares identical genomic abnormalities and functional disparities disappear in vivo and in prolonged in vitro assays. Importantly tail-derived T-ALL displays higher intrinsic resistance to cell-cycle-related drugs (ie, vincristine sulfate and cytarabine). Of note, T-ALL recovered from gonadal adipose tissues or from cocultures with adipocytes shares metabolic, cell-cycle, and phenotypic or chemoresistance features, with tail-derived T-ALL suggesting adipocytes may participate in the tail BM imprints on T-ALL. Altogether these results demonstrate that BM sites differentially orchestrate T-ALL propagation stamping specific features to leukemic cells such as quiescence and decreased response to cell-cycle-dependent chemotherapy.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Cahu X, Calvo J, Poglio S, et al. Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia. Blood Adv. 2017. PMID: 29296822. doi:10.1182/bloodadvances.2017004960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。